Quest Diagnostics
DGX
#1103
Rank
ยฃ12.97 B
Marketcap
ยฃ116.57
Share price
-1.37%
Change (1 day)
14.72%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total assets

Total assets on the balance sheet as of June 2024 : ยฃ10.57 B

According to Quest Diagnostics 's latest financial reports the company's total assets are ยฃ10.57 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Quest Diagnostics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ11.00 B3.73%
2022-12-31ยฃ10.61 B5.51%
2021-12-31ยฃ10.05 B-2.11%
2020-12-31ยฃ10.27 B6.16%
2019-12-31ยฃ9.67 B12.23%
2018-12-31ยฃ8.62 B10.96%
2017-12-31ยฃ7.77 B-5.06%
2016-12-31ยฃ8.18 B21.89%
2015-12-31ยฃ6.71 B6.06%
2014-12-31ยฃ6.33 B16.87%
2013-12-31ยฃ5.41 B-5.63%
2012-12-31ยฃ5.74 B-4.18%
2011-12-31ยฃ5.99 B8.11%
2010-12-31ยฃ5.54 B3.9%
2009-12-31ยฃ5.33 B-8.47%
2008-12-31ยฃ5.82 B35.86%
2007-12-31ยฃ4.28 B48.42%
2006-12-31ยฃ2.89 B-6.07%
2005-12-31ยฃ3.07 B40.4%
2004-12-31ยฃ2.19 B-9.64%
2003-12-31ยฃ2.42 B16.99%
2002-12-31ยฃ2.07 B2.57%
2001-12-31ยฃ2.02 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ12.73 B 20.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.7 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.25 B-88.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ71.21 M-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.25 B-59.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands